Despite knowing for years that giving antibiotics prior to surgery reduces the risk of infection, antimicrobial prophylaxis is administered properly only about half the time.
Despite knowing for years that giving antibiotics prior to surgery reduces the risk of infection, antimicrobial prophylaxis is administered properly only about half the time. According to a national retrospective cohort study involving 34,133 Medicare inpatients undergoing a variety of surgeries, only 0.7% of patients did not receive any prophylactic antimicrobial agent, but an antibiotic was administered within the recommended 1 hour prior to incision to only 55.7% of patients. Those undergoing cardiac or orthopedic surgery were more likely than others to receive an antibiotic within the recommended time frame. Almost 10% of patients received their first antimicrobial dose more than 4 hours after incision. On a more positive note, 92.6% of patients received the correct drug, that is, an antimicrobial agent consistent with published recommendations.
On the other hand, physicians seem reluctant to discontinue prophylactic antibiotics on schedule. The drugs were discontinued within the recommended 24 hours after surgery was completed in only 40.7% of patients. Those undergoing cardiac surgery or knee or hip arthroplasty were most likely to continue receiving antibiotics past the recommended cut-off, although the median duration of antibiotic prophylaxis was longest (57.0 hours) for patients undergoing colon surgery. Overall, 2 days after the end of surgery, 26.7% of patients were still receiving antibiotics, and 9.3% continued to receive antimicrobials for more than 96 hours after surgery.
Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: Baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140:174-182.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More